Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125682551 | 12568255 | 1 | I | 2016 | 20160713 | 20160718 | 20160718 | EXP | IT-ALLERGAN-1663063US | ALLERGAN | 72.00 | YR | M | Y | 0.00000 | 20160718 | CN | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125682551 | 12568255 | 1 | PS | Urorec | SILODOSIN | 1 | Oral | 8 MG, UNK | U | U | 22206 | 8 | MG | ||||||
125682551 | 12568255 | 2 | SS | APIDRA | INSULIN GLULISINE | 1 | 100 UNK, UNK | U | U | 5S372A | 0 | ||||||||
125682551 | 12568255 | 3 | SS | LANTUS | INSULIN GLARGINE | 1 | 6 IU, UNK | U | 0 | 6 | IU | ||||||||
125682551 | 12568255 | 4 | SS | LANTUS | INSULIN GLARGINE | 1 | 3 IU, UNK | U | 0 | 3 | IU | ||||||||
125682551 | 12568255 | 5 | SS | BLOPRESID | CANDESARTAN CILEXETILHYDROCHLOROTHIAZIDE | 1 | UNK, BID | U | U | 0 | BID | ||||||||
125682551 | 12568255 | 6 | SS | MADOPAR | BENSERAZIDE HYDROCHLORIDELEVODOPA | 1 | U | U | 0 | ||||||||||
125682551 | 12568255 | 7 | SS | AVODART | DUTASTERIDE | 1 | 0.5 MG, UNK | U | U | 0 | .5 | MG | QD | ||||||
125682551 | 12568255 | 8 | SS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | U | U | 0 | ||||||||||
125682551 | 12568255 | 9 | SS | NEUPRO | ROTIGOTINE | 1 | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125682551 | 12568255 | 1 | Product used for unknown indication |
125682551 | 12568255 | 2 | Diabetes mellitus |
125682551 | 12568255 | 3 | Diabetes mellitus |
125682551 | 12568255 | 5 | Product used for unknown indication |
125682551 | 12568255 | 6 | Product used for unknown indication |
125682551 | 12568255 | 7 | Product used for unknown indication |
125682551 | 12568255 | 8 | Product used for unknown indication |
125682551 | 12568255 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125682551 | 12568255 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125682551 | 12568255 | Anaphylactic shock | |
125682551 | 12568255 | Capillary disorder | |
125682551 | 12568255 | Hyperglycaemia | |
125682551 | 12568255 | Hypoglycaemia | |
125682551 | 12568255 | Joint swelling | |
125682551 | 12568255 | Nausea | |
125682551 | 12568255 | Paraesthesia | |
125682551 | 12568255 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |